ArticleScientific reports2026

Dehydroandrographolide attenuates Toll-like receptor signaling by dual inhibition of MyD88- and TRIF-dependent pathways.

Ye Eun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.